187 related articles for article (PubMed ID: 23830819)
1. Ligand-independent interaction of the type I interferon receptor complex is necessary to observe its biological activity.
Krause CD; Digioia G; Izotova LS; Xie J; Kim Y; Schwartz BJ; Mirochnitchenko OV; Pestka S
Cytokine; 2013 Oct; 64(1):286-97. PubMed ID: 23830819
[TBL] [Abstract][Full Text] [Related]
2. Analytical use of multi-protein Fluorescence Resonance Energy Transfer to demonstrate membrane-facilitated interactions within cytokine receptor complexes.
Krause CD; Izotova LS; Pestka S
Cytokine; 2013 Oct; 64(1):298-309. PubMed ID: 23769803
[TBL] [Abstract][Full Text] [Related]
3. Improving the spectral analysis of Fluorescence Resonance Energy Transfer in live cells: application to interferon receptors and Janus kinases.
Krause CD; Digioia G; Izotova LS; Pestka S
Cytokine; 2013 Oct; 64(1):272-85. PubMed ID: 23796694
[TBL] [Abstract][Full Text] [Related]
4. The intracellular domain of interferon-alpha receptor 2c (IFN-alphaR2c) chain is responsible for Stat activation.
Kotenko SV; Izotova LS; Mirochnitchenko OV; Lee C; Pestka S
Proc Natl Acad Sci U S A; 1999 Apr; 96(9):5007-12. PubMed ID: 10220409
[TBL] [Abstract][Full Text] [Related]
5. Luteolin sensitizes the antiproliferative effect of interferon α/β by activation of Janus kinase/signal transducer and activator of transcription pathway signaling through protein kinase A-mediated inhibition of protein tyrosine phosphatase SHP-2 in cancer cells.
Tai Z; Lin Y; He Y; Huang J; Guo J; Yang L; Zhang G; Wang F
Cell Signal; 2014 Mar; 26(3):619-28. PubMed ID: 24333668
[TBL] [Abstract][Full Text] [Related]
6. The WD motif-containing protein RACK-1 functions as a scaffold protein within the type I IFN receptor-signaling complex.
Usacheva A; Tian X; Sandoval R; Salvi D; Levy D; Colamonici OR
J Immunol; 2003 Sep; 171(6):2989-94. PubMed ID: 12960323
[TBL] [Abstract][Full Text] [Related]
7. The interferon receptors.
Pestka S
Semin Oncol; 1997 Jun; 24(3 Suppl 9):S9-18-S9-40. PubMed ID: 9208871
[TBL] [Abstract][Full Text] [Related]
8. Interferon alfa receptor expression and growth inhibition by interferon alfa in human liver cancer cell lines.
Yano H; Iemura A; Haramaki M; Ogasawara S; Takayama A; Akiba J; Kojiro M
Hepatology; 1999 Jun; 29(6):1708-17. PubMed ID: 10347112
[TBL] [Abstract][Full Text] [Related]
9. Down-modulation of type 1 interferon responses by receptor cross-competition for a shared Jak kinase.
Dondi E; Pattyn E; Lutfalla G; Van Ostade X; Uzé G; Pellegrini S; Tavernier J
J Biol Chem; 2001 Dec; 276(50):47004-12. PubMed ID: 11602573
[TBL] [Abstract][Full Text] [Related]
10. Reconstitution of a high affinity binding site for type I interferons.
Russell-Harde D; Pu H; Betts M; Harkins RN; Perez HD; Croze E
J Biol Chem; 1995 Nov; 270(44):26033-6. PubMed ID: 7592797
[TBL] [Abstract][Full Text] [Related]
11. Differential tyrosine phosphorylation of the IFNAR chain of the type I interferon receptor and of an associated surface protein in response to IFN-alpha and IFN-beta.
Abramovich C; Shulman LM; Ratovitski E; Harroch S; Tovey M; Eid P; Revel M
EMBO J; 1994 Dec; 13(24):5871-7. PubMed ID: 7813427
[TBL] [Abstract][Full Text] [Related]
12. Measles virus suppresses interferon-alpha signaling pathway: suppression of Jak1 phosphorylation and association of viral accessory proteins, C and V, with interferon-alpha receptor complex.
Yokota S; Saito H; Kubota T; Yokosawa N; Amano K; Fujii N
Virology; 2003 Feb; 306(1):135-46. PubMed ID: 12620806
[TBL] [Abstract][Full Text] [Related]
13. Expression of Hu-IFN-alphaR2 chain of type I interferon receptor in human hepatocellular carcinoma and non-cancerous tissues.
Takayama A; Yano H; Ogasawara S; Higaki K; Kojiro M
Int J Mol Med; 2000 Dec; 6(6):621-7. PubMed ID: 11078820
[TBL] [Abstract][Full Text] [Related]
14. Interferon-gamma inhibits interferon-alpha signalling in hepatic cells: evidence for the involvement of STAT1 induction and hyperexpression of STAT1 in chronic hepatitis C.
Radaeva S; Jaruga B; Kim WH; Heller T; Liang TJ; Gao B
Biochem J; 2004 Apr; 379(Pt 1):199-208. PubMed ID: 14690454
[TBL] [Abstract][Full Text] [Related]
15. Receptor for activated C-kinase (RACK-1), a WD motif-containing protein, specifically associates with the human type I IFN receptor.
Croze E; Usacheva A; Asarnow D; Minshall RD; Perez HD; Colamonici O
J Immunol; 2000 Nov; 165(9):5127-32. PubMed ID: 11046044
[TBL] [Abstract][Full Text] [Related]
16. Macrophages from nonobese diabetic mouse have a selective defect in IFN-γ but not IFN-α/β receptor pathway.
Lee MS; Kwon HJ; Kim HS
J Clin Immunol; 2012 Aug; 32(4):753-61. PubMed ID: 22396045
[TBL] [Abstract][Full Text] [Related]
17. Shp-2 tyrosine phosphatase functions as a negative regulator of the interferon-stimulated Jak/STAT pathway.
You M; Yu DH; Feng GS
Mol Cell Biol; 1999 Mar; 19(3):2416-24. PubMed ID: 10022928
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of interferon-stimulated JAK-STAT signaling by a tick-borne flavivirus and identification of NS5 as an interferon antagonist.
Best SM; Morris KL; Shannon JG; Robertson SJ; Mitzel DN; Park GS; Boer E; Wolfinbarger JB; Bloom ME
J Virol; 2005 Oct; 79(20):12828-39. PubMed ID: 16188985
[TBL] [Abstract][Full Text] [Related]
19. Catalytically active TYK2 is essential for interferon-beta-mediated phosphorylation of STAT3 and interferon-alpha receptor-1 (IFNAR-1) but not for activation of phosphoinositol 3-kinase.
Rani MR; Leaman DW; Han Y; Leung S; Croze E; Fish EN; Wolfman A; Ransohoff RM
J Biol Chem; 1999 Nov; 274(45):32507-11. PubMed ID: 10542297
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of alpha interferon but not gamma interferon signal transduction by phorbol esters is mediated by a tyrosine phosphatase.
Petricoin E; David M; Igarashi K; Benjamin C; Ling L; Goelz S; Finbloom DS; Larner AC
Mol Cell Biol; 1996 Apr; 16(4):1419-24. PubMed ID: 8657115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
